Andrew Chan

Andrew Chan - The International Aspirin Foundation Andrew Chan - The International Aspirin Foundation Andrew Chan - The International Aspirin Foundation  v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v vv v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v v

mgh-logo-gastroenterology-2x










Name: Andrew T. Chan MD, MPH

Academic Affiliations: Chief, Clinical and Translational Epidemiology Unit,  Vice Chair, Division of Gastroenterology, Massachusetts General Hospital, Boston, Co-leader, Cancer Epidemiology Program, Dana-Farber/Harvard Cancer Center, Boston.

Discipline: Gastroenterology

Scientific Interests:

  1. The role of aspirin in the prevention of colorectal cancer and other cancers
  2. The role of the gut microbiome in colorectal cancer and other chronic gastrointestinal diseases, including inflammatory bowel disease and diverticulitis
  3. The role of diet and lifestyle in colorectal cancer and other chronic gastrointestinal cancers

Declaration of Conflicts of Interest:

AACR Honors Dr. Andrew T. Chan With 2019 AACR-Waun Ki Hong Award

Click here to find the press release.

I received consultant Bayer and Pfizer, Inc.

I received grant support for investigator-initiated research from:

  • National Institutes of Health
  • National Cancer Institute
  • Crohn’s and Colitis Foundation
  • Bayer AG

    Andrew Chan is pictured here with AACR President Elizabeth Jaffee (left) and AACR         CEO Margaret Foti (right).